AstraZeneca PLC Bloodthinner, Brilinta Goes Before U.S. Experts Today

July 28, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- AstraZeneca Plc's experimental blood thinner goes before U.S. advisers on Wednesday, facing questions over why a trial of the potential blockbuster drug failed to cut heart attacks and deaths in North American patients.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

AstraZeneca Pharmaceuticals LP